Original research article BACKGROUND: Previous studies have found that women and black patients eligible for a primary prevention implantable cardioverterdefibrillator (ICD) are less likely than men or white patients to receive one.
METHODS:We performed an observational analysis of the Get With The Guidelines-Heart Failure Program from January 1, 2011, to March 21, 2014. Patients admitted with heart failure and an ejection fraction ≤35% without an ICD were included. Rates of ICD counseling among eligible patients and ICD receipt among counseled patients were examined by sex and race/ethnicity.
RESULTS:Among 21 059 patients from 236 sites, 4755 (22.6%) received predischarge ICD counseling. Women were counseled less frequently than men (19.3% versus 24.6%, P<0.001, adjusted odds ratio [OR], 0.84; 95% confidence interval [CI], 0.78-0.91). Racial and ethnic minorities were less likely to receive counseling than white patients (black 22.6%, Hispanic 18.6%, other race/ethnic group 14.4% versus white 24.3%, P<0.001 for each): adjusted OR versus white, 0.69; 95% CI, 0.63 to 0.76 for black patients; adjusted OR, 0.62; 95% CI, 0.55 to 0.70 for Hispanic patients; adjusted OR, 0.53; 95% CI, 0.43 to 0.65 for other patients. Among the 4755 counseled patients, 2977 (62.6%) received an ICD or had one planned for placement after hospital stay. Among those counseled, women and men were similarly likely to receive an ICD (adjusted OR, 1.13; 95% CI, 0.99-1.29). However, black (adjusted OR, 0.70; 95% CI, 0.56-0.88) and Hispanic patients (adjusted OR, 0.68; 95% CI, 0.46-1.01) were less likely to receive an ICD.
CONCLUSIONS:Up to 4 of 5 hospitalized patients with heart failure eligible for ICD counseling did not receive it, particularly women and minority patients. Among counseled patients, ICD use differences by race and ethnicity persisted. 518 s udden cardiac death is a major public health hazard, accounting for >200 000 deaths annually and 40% to 50% of years of potential life lost from heart disease. 1 The implantable cardioverter-defibrillator (ICD) can abort sudden cardiac death by terminating malignant arrhythmias and thereby confers a survival benefit to at-risk patients. [2][3][4][5] Heart failure (HF) with reduced left ventricular ejection fraction is one of the major risk factors for sudden cardiac death in current clinical practice. As a consequence, professional societies recommend that certain patients with reduced left ventricular ejection fraction receive an ICD. 6 In 2012, ICD counseling was established as a metric of HF quality of care by the American College of Cardiology and the American Heart Association.
7Previous studies documented low rates of ICD use among those eligible, particularly among women and minorities. In a previous analysis of Get With The Guidelines (GWTG)-HF, only 1 in 3 potentially eligible patients actually received an ICD or was discharged with plans to receive one. 8 After accounting for other demographic and hospital factors, women and black patients were approximately one-third less likely...